SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-102244
Filing Date
2021-03-31
Accepted
2021-03-31 16:04:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d239939ddefa14a.htm DEFA14A 15388
2 GRAPHIC g239939gra003.jpg GRAPHIC 171853
3 GRAPHIC g239939gra004.jpg GRAPHIC 106332
  Complete submission text file 0001193125-21-102244.txt   399753
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36327 | Film No.: 21793220
SIC: 2834 Pharmaceutical Preparations